Califf Floats Third-Party Supply Chain Monitoring To Fight Product Shortages

The US FDA commissioner’s call for the agency or someone else to watch supply chains and anticipate problems sounds a lot like a generics industry idea from 2011.

Supply chain
Could the FDA or another entity become a medical product supply chain monitor as Robert Califf suggested? • Source: Shutterstock

Robert Califf’s quest for increased oversight and monitoring of the medical product supply chain sounds like an old generic industry idea intended to help avert drug shortages.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Manufacturing

More from Compliance